UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.924

Sortiert nach

Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection

Gene therapy, 2011-04, Vol.18 (4), p.326-333

2011

Volltextzugriff (PDF)

Endogenous knockdown of survivin improves chemotherapeutic response in ALL models

Leukemia, 2012-02, Vol.26 (2), p.271-279

2012

Volltextzugriff (PDF)

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck

Cancer chemotherapy and pharmacology, 2015-07, Vol.76 (1), p.13-20

2015

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer

Journal of clinical oncology, 2000-02, Vol.18 (4), p.927-941

2000

Volltextzugriff (PDF)

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen

Journal of clinical oncology, 1996-03, Vol.14 (3), p.925-934

1996

Volltextzugriff (PDF)

Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn

The Journal of biological chemistry, 1993-10, Vol.268 (28), p.20725-20728

1993

Volltextzugriff (PDF)

Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody

Leukemia, 2005-06, Vol.19 (6), p.1064-1069

2005

Volltextzugriff (PDF)

Post-therapy serum prostate-specific antigen level and survival in patients With androgen-independent prostate Cancer

JNCI : Journal of the National Cancer Institute, 1999-02, Vol.91 (3), p.244-251

1999

Volltextzugriff (PDF)

Combined autologous CD30.CAR‐T cells and nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma after failure of frontline therapy (ACTION study)

Hematological oncology, 2023-06, Vol.41 (S2), p.524-525

2023

Volltextzugriff (PDF)

Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation

Molecular and Cellular Biology, 1988-10, Vol.8 (10), p.4353-4361

1988

Volltextzugriff (PDF)

Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma

Haematologica (Roma), 2009-10, Vol.94 (10), p.1456-1459

2009

Volltextzugriff (PDF)

Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas

Seminars in oncology, 1998-04, Vol.25 (2), p.33-39

1998

Volltextzugriff (PDF)

The interleukin-2 receptor : a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia

Blood, 1993-09, Vol.82 (6), p.1701-1712

1993

Volltextzugriff (PDF)

Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine

Journal of clinical oncology, 1996-03, Vol.14 (3), p.935-940

1996

Volltextzugriff (PDF)

Effects of the tyrosine‐kinase inhibitor geldanamycin on ligand‐induced HER‐2/NEU activation, receptor expression and proliferation of HER‐2‐positive malignant cell lines

International journal of cancer, 1997-01, Vol.70 (2), p.221-229

1997

Volltextzugriff (PDF)

Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer

Clinical cancer research, 2000-02, Vol.6 (2), p.406

2000

Volltextzugriff (PDF)

Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft

Cancer Immunology, Immunotherapy, 2005-04, Vol.54 (4), p.315-327

2005

Volltextzugriff (PDF)

No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120

Nature (London), 1990-12, Vol.348 (6301), p.557-560

1990

Volltextzugriff (PDF)

Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cells

Journal of Virology, 1989-05, Vol.63 (5), p.2343-2347

1989

Volltextzugriff (PDF)

Non-amine based analogs of lavendustin A as protein-tyrosine kinase inhibitors

Journal of medicinal chemistry, 1993-10, Vol.36 (20), p.3010-3014

1993

Volltextzugriff (PDF)

Hydroxylated 2-(5'-salicyl)naphthalenes as protein-tyrosine kinase inhibitors

Journal of medicinal chemistry, 1993-10, Vol.36 (20), p.3015-3020

1993

Volltextzugriff (PDF)

Akathisia associated with prochlorperazine as an antiemetic: a case report

Annals of oncology, 1996-01, Vol.7 (1), p.103

1996

Volltextzugriff (PDF)

1197PA phase I study of Sym021, an anti-PD-1 antibody (Ab), alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression

The Journal of clinical investigation, 1996-09, Vol.98 (6), p.1290-1297

1996

Volltextzugriff (PDF)

T-Lymphocyte Interleukin 2-Dependent Tyrosine Protein Kinase Signal Transduction Involves the Activation of p56lck

Proceedings of the National Academy of Sciences - PNAS, 1991-03, Vol.88 (5), p.1996-2000

1991

Volltextzugriff (PDF)

1 – 25 von 1.924

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.683)
Mit Volltextzugriff
(1.752)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.027)
Life Sciences & Biomedicine
(543)
Physical Sciences
(478)
Humans
(417)
Physics
(377)
Female
(269)
Natural Sciences
(244)
Naturvetenskap
(244)
Fysik
(243)
Subatomic Physics
(239)
Subatomär Fysik
(239)
Male
(233)
Biological And Medical Sciences
(222)
Physics Of Elementary Particles And Fields
(208)
Animals
(167)
Medical Sciences
(162)
Nuclear Physics
(153)
Technology
(149)
Physics, Particles & Fields
(148)
Middle Aged
(144)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection

Endogenous knockdown of survivin improves chemotherapeutic response in ALL models

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck

Phase I and Pharmacokinetic Study of Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen

Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn

Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody

Post-therapy serum prostate-specific antigen level and survival in patients With androgen-independent prostate Cancer

Combined autologous CD30.CAR‐T cells and nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma after failure of frontline therapy (ACTION study)

Alterations of the lymphocyte-specific protein tyrosine kinase (p56lck) during T-cell activation

Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma

Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas

The interleukin-2 receptor : a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia

Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine

Effects of the tyrosine‐kinase inhibitor geldanamycin on ligand‐induced HER‐2/NEU activation, receptor expression and proliferation of HER‐2‐positive malignant cell lines

Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer

Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft

No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120

Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cells

Non-amine based analogs of lavendustin A as protein-tyrosine kinase inhibitors

Hydroxylated 2-(5'-salicyl)naphthalenes as protein-tyrosine kinase inhibitors

Akathisia associated with prochlorperazine as an antiemetic: a case report

1197PA phase I study of Sym021, an anti-PD-1 antibody (Ab), alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)

HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression

T-Lymphocyte Interleukin 2-Dependent Tyrosine Protein Kinase Signal Transduction Involves the Activation of p56lck

Suchergebnisse filtern